Utilité du dosage de la CRP dans le diagnostic, le pronostic et le suivi de la pneumonie acquise dans la communauté [Role of C-reactive protein in the diagnosis, prognosis and follow-up of community-acquired pneumonia].


Autoria(s): Bauer S.; Lamy O.
Data(s)

2010

Resumo

Community-acquired pneumonia (CAP) is a major clinical problem in terms of morbidity, mortality, and use of hospital resources. It is well recognized that a delay in making the diagnosis and instituting appropriate antibiotic treatment is associated with an increased mortality. C-reactive protein may be helpful in the management of patients with CAP. CRP is widely used in the management of CAP, including diagnosis, prognosis and follow-up. But its usefulness is not known. The aim of this systematic review was to evaluate the usefulness of CRP in the diagnosis, prognosis and follow-up of CAP.

Identificador

http://serval.unil.ch/?id=serval:BIB_C63AA158E165

isbn:1660-9379[print], 1660-9379[linking]

pmid:21140960

Idioma(s)

fr

Fonte

Revue Médicale Suisse, vol. 6, no. 269, pp. 2068-70, 2072-3

Palavras-Chave #Anti-Bacterial Agents/therapeutic use; Biological Markers/blood; C-Reactive Protein/metabolism; Community-Acquired Infections/blood; Community-Acquired Infections/diagnosis; Diagnosis, Differential; Follow-Up Studies; Humans; Pneumonia, Bacterial/blood; Pneumonia, Bacterial/diagnosis; Prognosis; Severity of Illness Index
Tipo

info:eu-repo/semantics/review

article